<DOC>
	<DOCNO>NCT00812331</DOCNO>
	<brief_summary>The purpose study assess anti-viral activity ( inhibition viral growth ) TMC435350 genotype 2,3,4,5 6 hepatitis C virus infect participant never receive treatment hepatitis C infection .</brief_summary>
	<brief_title>A Study Assess Anti-viral Activity , Safety , Tolerability Pharmacokinetics TMC435350 Participants Infected With Hepatitis C-Virus ( HCV )</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) study assess antiviral activity , safety , tolerability pharmacokinetics ( explores body medication ) TMC435350 hereafter refer TMC435 . Approximately 40 participant divide 5 group per genotype ( 8 participant group ) . The study include screen phase ( 6 week ) , treatment phase ( 7 day ) follow-up phase ( 30-35 day last dose study medication ) . Safety evaluation include assessment adverse event , clinical laboratory test cardiovascular safety .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<criteria>Participants document chronic genotype 2 , 3 , 4 , 5 6 hepatitis C virus ( HCV ) infection Participants never receive treatment HCV infection Participants either cirrhosis Child Pugh A liver disease Participants plasma HCV genotype level equal 100 , 000 IU/mL screen Evidence Child Pugh B C liver disease screening , decompensated liver disease define prior current history ascities , hepatic encephalopathy , esophageal gastric varix Participants diagnose suspected hepatocellular carcinoma Participants coinfected human immunodeficiency virus type 1 2 , hepatitis A B virus infection active tuberculosis screen Participants active clinically significant disease , medical history physical examination electrocardiogram finding screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>TMC435</keyword>
</DOC>